Category: Index Fund |
Launch Date: 14-12-2022 |
Asset Class: |
Benchmark: NIFTY Pharma TRI |
Expense Ratio: 0.97% As on ( 31-03-2025) |
Status: Open Ended Schemes |
Minimum Investment: 1000.0 |
Minimum Topup: 1000.0 |
Total Assets: 80.6 Cr As on ( 31-03-2025) |
Turn over: 180 |
1-Year Ret (%) | 3-Yrs Ret (%) | 5-Yrs Ret (%) | 10-Yrs Ret (%) | Since Launch Ret (%) | |
---|---|---|---|---|---|
ICICI Prudential Nifty Pharma Index Fund - Growth | 12.46 | - | - | - | 23.5 |
Nifty Pharma TRI | 13.84 | 18.02 | 19.11 | 6.72 | 14.46 |
Index Fund | 5.78 | 13.1 | 21.14 | 11.93 | 7.69 |
Kayzad Eghlim, Nishit Patel, Kewal Shah, Priya Sridhar
The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Key Statistics | Volatility | Sharpe Ratio | Alpha | Beta | Yield to Maturity | Average Maturity |
---|---|---|---|---|---|---|
ICICI Prudential Nifty Pharma Index Fund - Growth | ||||||
Index Fund | - | - | - | - | - | - |